Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Respir Med ; 170: 106024, 2020.
Article in English | MEDLINE | ID: mdl-32843166

ABSTRACT

BACKGROUND: Though the relationship between chronic rhinosinusitis (CRS) and lower airway diseases is well recognized, the impact of CRS on bronchial wall structure has not been elucidated. Here, we evaluated the bronchial wall structure of CRS patients with or without diagnosed airway diseases by three-dimensional computed tomography (3D-CT). METHODS: Subjects who underwent both chest CT and sinus CT within a year were recruited from consecutive medical records. CRS was defined as a Lund-Mackay score (LMS) of over 5 points. Airway dimensions were measured using validated software. Standard blood tests and pulmonary function tests were performed, and their correlation with airway thickness was examined. RESULTS: One-hundred-seventy-two patients were recruited (93 CRS subjects and 79 non-CRS subjects). The bronchial walls of CRS subjects were significantly thicker than those of non-CRS subjects. CRS and asthma were related to bronchial wall thickening by multivariate linear regression analysis adjusted for age, smoking status, and chest symptoms. In addition, LMS was significantly correlated with bronchial wall thickening. CONCLUSION: Airway walls in CRS subjects were thicker than those in non-CRS subjects and associated with the severity of CRS. These data indicate strong relationship between upper and lower airways regardless of chest symptoms or diagnosed airway diseases.


Subject(s)
Bronchi/diagnostic imaging , Bronchi/pathology , Rhinitis/diagnostic imaging , Rhinitis/pathology , Sinusitis/diagnostic imaging , Sinusitis/pathology , Aged , Chronic Disease , Female , Humans , Male , Middle Aged , Multidetector Computed Tomography , Paranasal Sinuses/diagnostic imaging , Radiography, Thoracic , Severity of Illness Index
2.
Allergol Int ; 68(4): 515-520, 2019 Oct.
Article in English | MEDLINE | ID: mdl-31257167

ABSTRACT

BACKGROUND: Asthma often coexists with chronic rhinosinusitis (CRS). Recent studies revealed that sinus inflammation in asthmatic patients was related to eosinophilic inflammation. However, the relationship between the severity of CRS and four different sputum inflammatory phenotypes as defined by the proportion of eosinophils and neutrophils is unknown. The aim of this study was to examine the impact of the severity of CRS on lower airway and systemic inflammation in asthmatic patients. METHODS: We enrolled 57 adult asthmatic patients who underwent sinus computed tomography (CT). The severity of CRS was evaluated by the Lund-Mackay score (LMS). The induced sputum inflammatory phenotype was defined by eosinophils (≥/<2%) and neutrophils (≥/<60%). Peripheral blood mononuclear cells (PBMC) were collected to examine cytokine productions. RESULTS: The median LMS of subjects was 6 (interquartile range, 0-11.5). The sputum inflammatory cell phenotype was categorized as paucicellular (n = 14), neutrophilic (n = 11), eosinophilic (n = 20), or mixed (n = 12). LMS was positively correlated with the percentage of blood eosinophils, sputum eosinophils, and mean fluorescence intensity (MFI) of IL-5 on CD4+ T cells. In the severe CRS group (LMS, 12-24), the number of mixed cellular phenotypes was higher than that in the group without CRS (LMS, 0-4) and mild-to-moderate CRS group (LMS, 5-11). CONCLUSIONS: In asthmatic patients with severe CRS, the proportion of the mixed cellular inflammatory phenotype was increased as well as eosinophilic inflammation.


Subject(s)
Asthma/complications , Asthma/pathology , Rhinitis/complications , Sinusitis/complications , Aged , Asthma/diagnostic imaging , Asthma/metabolism , Biomarkers , Eosinophilia/pathology , Female , Humans , Immunophenotyping , Leukocyte Count , Lymphocytes/immunology , Lymphocytes/metabolism , Male , Middle Aged , Neutrophils/immunology , Neutrophils/metabolism , Neutrophils/pathology , Phenotype , Rhinitis/diagnosis , Severity of Illness Index , Sinusitis/diagnosis , Tomography, X-Ray Computed
3.
Clin Case Rep ; 6(4): 653-657, 2018 04.
Article in English | MEDLINE | ID: mdl-29636934

ABSTRACT

The association between thrombosis and cancer has been recognized since Trousseau's report in 1865. We present a case of bladder squamous cell carcinoma associated with multiple cerebral infarctions. This patient was diagnosed as having Trousseau's syndrome and received radiotherapy for bladder cancer treatment, along with anticoagulation therapy.

4.
Gan To Kagaku Ryoho ; 36(6): 979-81, 2009 Jun.
Article in Japanese | MEDLINE | ID: mdl-19542719

ABSTRACT

Two unresectable advanced gastric cancer cases with peritoneal metastases were successfully treated by the combination therapy of S-1 and paclitaxel. S-1 (1.25m(2): 80 mg/day, 1.25m(2)-1.50m(2)<:120 mg/day) was administered orally for 14 consecutive days followed by 14 days rest and a 2-hour infusion of paclitaxel (50 mg/m(2)) was administered on day 1 and 15 of each course. Treatment was repeated every 4 weeks unless disease progression or severe adverse effects were observed. Case 1: 65-year-old male (performance status: PS 3) with type 1 gastric cancer with malignant ascites. Case 2: 66-year-old male (PS3) with peritoneal metastases whose primary gastric lesion was surgically resected. Partial response was obtained in the former and complete response in the latter. Combination therapy of S-1 and paclitaxel can be highly recommended for patients with inoperable gastric cancer with poor PS.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Peritoneal Neoplasms/secondary , Stomach Neoplasms/drug therapy , Stomach Neoplasms/pathology , Aged , Antimetabolites, Antineoplastic/administration & dosage , Antineoplastic Agents, Phytogenic/administration & dosage , Drug Administration Schedule , Drug Combinations , Humans , Male , Oxonic Acid/administration & dosage , Paclitaxel/administration & dosage , Peritonitis/etiology , Tegafur/administration & dosage
5.
Nagoya J Med Sci ; 70(3-4): 127-33, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18954031

ABSTRACT

Intraosseous glomus tumors of bone are extremely rare. We report a case of an intraosseous glomus tumor of the ulna. The patient was a 25-year-old woman who had a three-month history of a palpable mass in her right forearm with spontaneous pain. Radiographs showed cortical hypertrophy and a shell-like bone formation surrounding the small osteolytic lesion within the cortex of the ulna diaphysis. The differential diagnosis included benign bone-forming tumors, such as osteoid osteoma. The patient was treated with an en-bloc resection and filling with beta-TCP. Up to one year after the operation there has been no evidence of recurrence.


Subject(s)
Bone Neoplasms/diagnostic imaging , Glomus Tumor/diagnostic imaging , Ulna , Adult , Bone Neoplasms/pathology , Bone Neoplasms/surgery , Female , Glomus Tumor/pathology , Glomus Tumor/surgery , Humans , Radiography
6.
Oncol Rep ; 20(2): 259-64, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18636184

ABSTRACT

We report on two patients, successfully treated by the combination therapy of S-1 and 24-h infusion of cisplatin (CDDP), who were initially diagnosed with unresectable stage 4 advanced gastric cancer. Each patient had a very good clinical response and underwent curative gastrectomy after completion of 14 and 10 courses of S-1/CDDP chemotherapy, respectively. A microscopically detailed examination of surgically obtained specimens showed the complete disappearance of malignant cells in the two cases. S-1/CDDP combination therapy can, therefore, be highly active in incurable advanced gastric carcinoma.


Subject(s)
Adenocarcinoma/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Stomach Neoplasms/drug therapy , Adenocarcinoma/secondary , Adenocarcinoma/surgery , Adult , Aged , Aged, 80 and over , Bone Neoplasms/drug therapy , Bone Neoplasms/secondary , Cisplatin/administration & dosage , Drug Combinations , Female , Humans , Infusions, Intravenous , Liver Neoplasms/drug therapy , Liver Neoplasms/secondary , Lymphatic Metastasis , Male , Middle Aged , Oxonic Acid/administration & dosage , Peritoneal Neoplasms/drug therapy , Peritoneal Neoplasms/secondary , Prognosis , Remission Induction , Stomach Neoplasms/pathology , Stomach Neoplasms/surgery , Survival Rate , Tegafur/administration & dosage
7.
Gen Comp Endocrinol ; 157(1): 63-9, 2008 May 15.
Article in English | MEDLINE | ID: mdl-18448104

ABSTRACT

Physiological function of arginine vasotocin (AVT) and effect of receptor antagonists of vasopressin were electrophysiologically investigated on transepithelial transport of ions in the abdominal skin of Hyla japonica and Rana nigromaculata by means of the Ussing chamber system. Administrations of AVT and forskolin (adenylate cyclase activator) in the serosal side of normal Ringer's solution significantly increased transepithelial potential difference (PD) and short-circuit current (Isc) accounting for Na(+) influx, mucosal to serosal direction, across the skin of H. japonica. In contrast, AVT administrations significantly decreased PD but not Isc on the skin of R. nigromaculata in a concentration-dependent manner ranging from 10(-11) to 10(-8)M. Administration of 10(-5)M forskolin also significantly decreased PD in normal and low Na(+) Ringer's solution and in the presence of amiloride (Na(+) channel blocker) on the mucosal side of normal Ringer's solution. On the other hand, forskolin significantly increased PD and Isc in the Cl(-) free Ringer's solution. These results suggested that AVT and forskolin stimulated mainly Cl(-) influx across the skin of R. nigromaculata. In two frog species, the AVT actions on ion transports were inhibited by pretreatment of OPC-31260 (a vasopressin V(2) receptor antagonist) but not OPC-21268 (a vasopressin V(1) receptor antagonist). These results suggested that AVT activates adenylate cyclase via V(2)-like receptor and stimulates actively net Na(+) and net Cl(-) transports in the abdominal skin of H. japonica and R. nigromaculata, respectively.


Subject(s)
Antidiuretic Hormone Receptor Antagonists , Chlorides/metabolism , Skin/metabolism , Sodium/metabolism , Vasotocin/pharmacology , Animals , Anura , Benzazepines/pharmacology , Biological Transport/drug effects , Biological Transport/physiology , Colforsin/pharmacology , Dose-Response Relationship, Drug , Electrophysiology , Female , In Vitro Techniques , Male , Piperidines/pharmacology , Quinolones/pharmacology , Receptors, Vasopressin/physiology , Species Specificity , Time Factors
8.
Dig Dis Sci ; 51(4): 641-6, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16614982

ABSTRACT

Non-Helicobacter bacteria can be cultured from the gastric mucosa in adults but in children, there are no studies about such microflora. The purpose of this study, therefore, was to clarify whether gastric biota develops in children. In 10 children and 10 adults or elderly (5 H. pylori-infected and 5 uninfected in each group), biopsy specimens of the gastric antrum and corpus and gastric juice were studied for bacterial examinations and the data were compared between both age groups in relation to H. pylori status and luminal pH. Bacterial genera and species were analyzed using both culture and real-time polymerase chain reaction (PCR) with the 52 genus- and species-specific primer sets. Non-Helicobacter bacteria in the mucosa were cultured from all adult patients, whereas microorganisms were cultured in only one child (p < .001). Gastric pH was lower in children (median, 1.4) than in adults (median, 2.6) (p < .005). The grade of endoscopic gastric atrophy was moderate or severe in 8 adults, but absent or mild in all 10 children. Among adults, there was a significant positive correlation between gastric pH and total bacterial counts of both the mucosa and juice. These data indicate that impaired gastric acid secretion associated with long-term H. pylori infection enables non-Helicobacter bacteria to colonize in the human stomach. Such microorganisms rarely colonize in the gastric mucosa in children regardless of H. pylori status.


Subject(s)
Gastric Mucosa/microbiology , Gastritis, Atrophic/diagnosis , Helicobacter Infections/diagnosis , Helicobacter pylori/isolation & purification , Adolescent , Adult , Age Factors , Aged , Base Sequence , Biopsy, Needle , Child , Cohort Studies , Colony Count, Microbial , DNA, Bacterial/analysis , Dyspepsia/diagnosis , Dyspepsia/etiology , Female , Follow-Up Studies , Gastric Acidity Determination , Gastric Mucosa/pathology , Gastroscopy , Helicobacter Infections/epidemiology , Humans , Hydrogen-Ion Concentration , Immunohistochemistry , Male , Middle Aged , Molecular Sequence Data , Probability , Reverse Transcriptase Polymerase Chain Reaction , Risk Factors , Sensitivity and Specificity
9.
Auris Nasus Larynx ; 31(1): 89-93, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15041061

ABSTRACT

A case of composite lymphoma (CL) arisen in the parotid gland in a 58-year-old male is reported. Histologically, most of the tumor region was follicular lymphoma (FL), grade 2. However complicating classical Hodgkin lymphoma (CHL) was noted inside the lesion. There have been a few reports of composite lymphoma, complicated by multiple histologic types in the same organ. Extra-nodal cases are particularly rare. This is a very significant case with regard to differences between B cell-derived non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) and its histological origin.


Subject(s)
Hodgkin Disease/pathology , Lymphoma, Follicular/pathology , Neoplasms, Multiple Primary/pathology , Parotid Gland/pathology , Parotid Neoplasms/pathology , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Hodgkin Disease/drug therapy , Hodgkin Disease/surgery , Humans , Immunohistochemistry , Lymphoma, Follicular/drug therapy , Lymphoma, Follicular/surgery , Male , Middle Aged , Neoplasms, Multiple Primary/drug therapy , Neoplasms, Multiple Primary/surgery , Parotid Gland/surgery , Parotid Neoplasms/drug therapy , Parotid Neoplasms/surgery , Prednisone/administration & dosage , Vincristine/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL
...